Suppr超能文献

二尖瓣脱垂继发二尖瓣反流的瓣膜重建结果。

Results of valve reconstruction for mitral regurgitation secondary to mitral valve prolapse.

作者信息

Penkoske P A, Ellis F H, Alexander S, Watkins E

出版信息

Am J Cardiol. 1985 Mar 1;55(6):735-8. doi: 10.1016/0002-9149(85)90147-x.

Abstract

Mitral valve prolapse (MVP), often the result of myxomatous degeneration of the mitral valve, is the most commonly known pathologic entity leading to pure mitral regurgitation (MR). Reconstruction of the mitral valve rather than replacement is particularly applicable to this pathologic defect, but is not often used in the U.S. Experience with reconstruction of the mitral valve for MR secondary to MVP during the period January 1970 to January 1984 was reviewed. A total of 479 patients with mitral valve disease underwent operation during this period, 82 (17%) of whom had MR secondary to MVP. Thirty-one patients (6%) had valve reconstruction by a technique of leaflet plication and posteromedial anuloplasty. Eleven of these patients had associated cardiac disease requiring correction: 2 requiring aortic valve replacement and 9 requiring coronary artery bypass grafting procedures. One hospital death (3%) and 6 late deaths (19%) occurred, of which only 3 were related to cardiac factors. Major complications included recurrent MR in 5 patients and cerebral embolus in 1 patient. The adjusted 5-year survival rate was 89 +/- 6 (mean +/- standard error of the mean), and the overall survival rate of patients free of cardiac-related complications was 73 +/- 9%. Thus, reconstruction of the mitral valve is a highly effective surgical approach to the management of symptomatic patients with MR secondary to MVP, and its use is favored over replacement in the management of these patients.

摘要

二尖瓣脱垂(MVP)通常是二尖瓣黏液样变性的结果,是导致单纯二尖瓣反流(MR)最常见的病理实体。二尖瓣重建而非置换尤其适用于这种病理缺陷,但在美国并不常用。回顾了1970年1月至1984年1月期间因MVP继发MR而进行二尖瓣重建的经验。在此期间,共有479例二尖瓣疾病患者接受了手术,其中82例(17%)因MVP继发MR。31例患者(6%)通过瓣叶折叠和后内侧瓣环成形术进行了瓣膜重建。这些患者中有11例合并需要矫正的心脏病:2例需要主动脉瓣置换,9例需要冠状动脉旁路移植术。发生1例医院死亡(3%)和6例晚期死亡(19%),其中仅3例与心脏因素有关。主要并发症包括5例患者出现复发性MR和1例患者出现脑栓塞。调整后的5年生存率为89±6(均值±均值标准误差),无心脏相关并发症患者的总体生存率为73±9%。因此,二尖瓣重建是治疗MVP继发MR有症状患者的一种高效手术方法,在这些患者的治疗中,其应用优于瓣膜置换。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验